We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

142 hedge funds and large institutions have $584M invested in Cytokinetics in 2019 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 41 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 41

16.24% more ownership

Funds ownership: 76.89% → 93.13% (+16%)

14% more capital invested

Capital invested by funds: $513M → $584M (+$70.5M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 25

4% less funds holding

Funds holding: 148 → 142 (-6)

13% less call options, than puts

Call options by funds: $2.59M | Put options by funds: $2.98M

Holders
142
Holders Change
-6
Holders Change %
-4.05%
% of All Funds
2.8%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
25
Increased
51
Reduced
41
Closed
25
Calls
$2.59M
Puts
$2.98M
Net Calls
-$389K
Net Calls Change
-$3.94M

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$31.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$26.7M
3
Morgan Stanley
Morgan Stanley
New York
+$11.2M
4
Jennison Associates
Jennison Associates
New York
+$6.27M
5
Millennium Management
Millennium Management
New York
+$5.94M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$8.57M
2
OM
Opaleye Management
Massachusetts
-$7.4M
3
SI
Sofinnova Investments
California
-$2.4M
4
PVI
Pura Vida Investments
New York
-$2.14M
5
N
Nuveen
North Carolina
-$1.79M
Name Holding Trade Value Shares
Change 		Change in
Stake
LIA
126
LS Investment Advisors
Michigan
$20K – – –
LTFS
127
Ladenburg Thalmann Financial Services
Florida
$18K -$10.3K -1,000 -38%
FGAM
128
Financial Gravity Asset Management
Texas
$11K -$103 -10 -10%
GWM
129
Geneos Wealth Management
Colorado
$10K – – –
CHAM
130
Clear Harbor Asset Management
Connecticut
$5.84K +$5.65K +550 New
EWM
131
Edge Wealth Management
New York
$5K +$5.14K +500 New
FDCDDQ
132
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.24K – – –
GT
133
Glenmede Trust
Pennsylvania
$4K -$1.78K -173 -28%
Daiwa Securities Group
134
Daiwa Securities Group
Japan
$4K – – –
WAP
135
Wealthcare Advisory Partners
Pennsylvania
$4K – – –
TRCT
136
Tower Research Capital (TRC)
New York
$4K +$2.62K +255 +182%
VCM
137
Versant Capital Management
Arizona
$3K – – –
LJHT
138
Laurie J. Hall Trustee
$3K +$514 +50 +23%
HR
139
Howe & Rusling
New York
$2K – – –
US Bancorp
140
US Bancorp
Minnesota
$2K – – –
PFBT
141
Parkside Financial Bank & Trust
Missouri
$1K – – –
AG
142
Advisor Group
Arizona
$1K +$164 +16 +31%
OM
143
Opaleye Management
Massachusetts
– -$7.4M -650,000 Closed
SI
144
Sofinnova Investments
California
– -$2.4M -210,992 Closed
PVI
145
Pura Vida Investments
New York
– -$2.14M -188,096 Closed
OAM
146
Oxford Asset Management
United Kingdom
– -$1.78M -156,783 Closed
Assenagon Asset Management
147
Assenagon Asset Management
Luxembourg
– -$689K -60,583 Closed
PAM
148
Panagora Asset Management
Massachusetts
– -$618K -54,313 Closed
RJFSA
149
Raymond James Financial Services Advisors
Florida
– -$298K -26,204 Closed
Dimensional Fund Advisors
150
Dimensional Fund Advisors
Texas
– -$284K -24,940 Closed
3 4 5
6
7

CYTK Hedge Fund Activity: Q4 2019 in Review

142 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2019, worth a combined $584M — up 14% from $513M a quarter earlier.

Fund positioning in CYTK was balanced in Q4 2019: 25 funds opened new positions, 25 closed out, 51 added to existing stakes and 41 trimmed.

The largest buyer was BVF Inc, adding an estimated $31.2M. The largest seller was Federated Hermes, cutting an estimated $8.57M.

  • 142 institutional investors held Cytokinetics (CYTK) as of Q4 2019, down from 148 in Q3 2019.
  • Funds reported $584M of Cytokinetics stock for Q4 2019, up 14% quarter-over-quarter.
  • 25 funds opened new Cytokinetics positions in Q4 2019 and 25 closed out, a net change of 0 holders.
  • The largest Cytokinetics buyer in Q4 2019 was BVF Inc, an estimated $31.2M added.
  • The largest Cytokinetics seller in Q4 2019 was Federated Hermes, an estimated $8.57M sold.

Based on aggregated 13F filings for Q4 2019.